Karnani Vikram 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Collegium (COLL) CEO Vikram Karnani Receives Stock Award
What Happened
Vikram Karnani, President, CEO and a director of Collegium Pharmaceutical (COLL), received equity awards on February 10, 2026: 79,264 restricted stock units (RSUs) and 32,531 performance share units (PSUs) (both reported as acquisitions at $0.00). To satisfy withholding taxes on the vested awards, 11,296 shares were withheld/disposed at $46.75 per share, totaling $528,088.
Key Details
- Transaction date: February 10, 2026 (filed February 12, 2026 — timely filed).
- Awards: 79,264 RSUs (grant) and 32,531 PSUs (performance-vesting determined). Both reported as acquired at $0.00 per share.
- Tax withholding/disposition: 11,296 shares withheld at $46.75/share for $528,088 to cover taxes. (Code F—tax withholding.)
- Vesting/settlement notes: RSUs settle in shares; one-third vest on Feb 10, 2027, with the remainder vesting in equal annual installments over the next two years (footnote). PSUs vested because performance criteria were met (footnote).
- Misc. footnote: filing references 376 shares purchased under the company ESPP on July 18, 2025.
- Shares owned after the transaction: not specified in the provided filing details.
Context
RSUs and PSUs are compensation awards that convert to shares on vesting and reflect granted pay rather than open-market buying or selling. The 11,296-share disposition was a routine tax-withholding event (common when awards vest) and should not be read as an opportunistic sale of stock. The PSU portion reflects achievement of performance targets; the RSU portion follows a multi-year vesting schedule.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-02-10+79,264→ 176,629 total - Award
Common Stock
[F3]2026-02-10+32,531→ 209,160 total - Tax Payment
Common Stock
[F4]2026-02-10$46.75/sh−11,296$528,088→ 197,864 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Includes 376 shares acquired on July 18, 2025 under the Issuer's employee stock purchase plan.
- [F3]Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,531 performance share units ("PSUs") granted in the Issuer's 2025 fiscal year.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.